Page last updated: 2024-10-18

dalteparin and Atheroma

dalteparin has been researched along with Atheroma in 2 studies

Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)

Research Excerpts

ExcerptRelevanceReference
"Dalteparin may inhibit atherosclerotic lesions by downregulating the expression of LOX-1 protein."1.42Effect of dalteparin on atherosclerotic lesion formation in apolipoprotein E-deficient mice. ( Bao, H; Chen, D; Li, W; Miao, Y; Su, L; Yan, Z; Zhang, Q, 2015)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Artico, M1
RiganĂ², R1
Buttari, B1
Profumo, E1
Ionta, B1
Bosco, S1
Rasile, M1
Bianchi, E1
Bruno, M1
Fumagalli, L1
Su, L1
Zhang, Q1
Bao, H1
Li, W1
Miao, Y1
Yan, Z1
Chen, D1

Other Studies

2 other studies available for dalteparin and Atheroma

ArticleYear
Protective role of parnaparin in reducing systemic inflammation and atherosclerotic plaque formation in ApoE-/- mice.
    International journal of molecular medicine, 2011, Volume: 27, Issue:4

    Topics: Animals; Apolipoproteins E; Arteries; Disease Models, Animal; Fatty Liver; Fibrinolytic Agents; Gene

2011
Effect of dalteparin on atherosclerotic lesion formation in apolipoprotein E-deficient mice.
    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2015, Volume: 21, Issue:3

    Topics: Animals; Apolipoproteins E; Atherosclerosis; Dalteparin; Down-Regulation; Mice; Mice, Knockout; Plaq

2015